197 related articles for article (PubMed ID: 3501540)
21. Biochemical modulation in the treatment of advanced cancer: a study of combined leucovorin, fluorouracil, and iododeoxyuridine.
Marshall JL; Richmond E; DeLap RJ
Clin Cancer Res; 1996 Sep; 2(9):1475-80. PubMed ID: 9816323
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
[TBL] [Abstract][Full Text] [Related]
23. Comparison of unique leucovorin and 5-fluorouracil "escalating" and "maximum" dosage strategies.
Bruckner HW; Petrelli NJ; Stablein D; Novak J; Mayer R
NCI Monogr; 1987; (5):179-84. PubMed ID: 3501539
[TBL] [Abstract][Full Text] [Related]
24. Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer.
Scheithauer W; Depisch D; Kornek G; Pidlich J; Rosen H; Karall M; Prochaska M; Ernst A; Sebesta C; Eckhardt S
Cancer; 1994 Mar; 73(6):1562-8. PubMed ID: 8156482
[TBL] [Abstract][Full Text] [Related]
25. Biochemical and pharmacologic basis for potentiation of 5-fluorouracil action by leucovorin.
Rustum YM; Trave F; Zakrzewski SF; Petrelli N; Herrera L; Mittelman A; Arbuck SG; Creaven PJ
NCI Monogr; 1987; (5):165-70. PubMed ID: 2448653
[TBL] [Abstract][Full Text] [Related]
26. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
Poon MA; O'Connell MJ; Moertel CG; Wieand HS; Cullinan SA; Everson LK; Krook JE; Mailliard JA; Laurie JA; Tschetter LK
J Clin Oncol; 1989 Oct; 7(10):1407-18. PubMed ID: 2476530
[TBL] [Abstract][Full Text] [Related]
27. [Current status of chemotherapy for colonic, rectal and anal carcinoma].
Herrmann R
Schweiz Rundsch Med Prax; 1990 Jul; 79(29-30):896-8. PubMed ID: 2374860
[TBL] [Abstract][Full Text] [Related]
28. A controlled clinical trial including folinic acid at two distinct dose levels in combination with 5-fluorouracil (5FU) for the treatment of advanced colorectal cancer: experience of the Mayo Clinic and North Central Cancer Treatment Group.
O'Connell MJ
Adv Exp Med Biol; 1988; 244():173-84. PubMed ID: 2470245
[TBL] [Abstract][Full Text] [Related]
29. Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy.
Doroshow JH; Multhauf P; Leong L; Margolin K; Litchfield T; Akman S; Carr B; Bertrand M; Goldberg D; Blayney D
J Clin Oncol; 1990 Mar; 8(3):491-501. PubMed ID: 2407810
[TBL] [Abstract][Full Text] [Related]
30. Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. QUASAR Collaborative Group.
Lancet; 2000 May; 355(9215):1588-96. PubMed ID: 10821362
[TBL] [Abstract][Full Text] [Related]
31. Schedule-dependent enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cells in the presence of folinic acid.
Moran RG; Scanlon KL
Cancer Res; 1991 Sep; 51(17):4618-23. PubMed ID: 1831402
[TBL] [Abstract][Full Text] [Related]
32. Systemic therapy of colorectal cancer.
Hansen RM
Wis Med J; 1988 May; 87(5):27-9. PubMed ID: 3291406
[No Abstract] [Full Text] [Related]
33. Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer.
Hryniuk WM; Figueredo A; Goodyear M
Semin Oncol; 1987 Dec; 14(4 Suppl 4):3-11. PubMed ID: 3317849
[TBL] [Abstract][Full Text] [Related]
34. Retrospective comparative analysis of 5FU + low-dose folinic acid vs. 5FU + high-dose folinic acid in the treatment of metastatic colorectal cancer. The Ottawa experience.
Maroun JA; Cripps C; Goel R; Dahrouge S; Boisvert D
Am J Clin Oncol; 1997 Aug; 20(4):387-92. PubMed ID: 9256896
[TBL] [Abstract][Full Text] [Related]
35. Systemic therapy in metastatic colorectal cancer.
Hansen RM
Arch Intern Med; 1990 Nov; 150(11):2265-9. PubMed ID: 2241436
[TBL] [Abstract][Full Text] [Related]
36. Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid.
Grem JL; Hoth DF; Hamilton JM; King SA; Leyland-Jones B
Cancer Treat Rep; 1987 Dec; 71(12):1249-64. PubMed ID: 3319136
[No Abstract] [Full Text] [Related]
37. Sequential 5-fluorouracil, methotrexate, and calcium leucovorin in metastatic colorectal cancer.
Hansen RM; Banerjee TK; Davis HL; Zaentz SD; Schiferl EA; Ousley JL; Pogodzinski AE; Trump DL
Wis Med J; 1988 May; 87(5):20-3. PubMed ID: 3291405
[No Abstract] [Full Text] [Related]
38. Preclinical evaluation of novel, all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profiles.
Stutchbury TK; Vine KL; Locke JM; Chrisp JS; Bremner JB; Clingan PR; Ranson M
Anticancer Drugs; 2011 Jan; 22(1):24-34. PubMed ID: 20881836
[TBL] [Abstract][Full Text] [Related]
39. The effect of leucovorin on the therapeutic index of fluorouracil in cancer patients.
DeLap RJ
Yale J Biol Med; 1988; 61(1):23-34. PubMed ID: 3284210
[TBL] [Abstract][Full Text] [Related]
40. High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study.
Bertrand M; Doroshow JH; Multhauf P; Blayney DW; Carr BI; Cecchi G; Goldberg D; Leong L; Margolin K; Metter G
J Clin Oncol; 1986 Jul; 4(7):1058-61. PubMed ID: 3487626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
